Immune Checkpoint Inhibitors on Track for Better Personalization – Cancer Therapy Advisor
Emerging evidence suggests that a better understanding of T-cell behavior may help immune checkpoint inhibitors become more personalized.
Related Articles
Novel Postneoadjuvant Prognostic Breast Cancer Staging System
PURPOSEPrognostic staging after neoadjuvant chemotherapy (NACT) is not included in American Joint Commission on Cancer (AJCC) staging. This study addressed this deficiency by including responses…
Global practice patterns of sentinel lymph node biopsy in endometrial cancer: a survey from the European Network of Young Gynecologic Oncologists (ENYGO)
This survey aimed to evaluate trends in sentinel lymph node (SLN) biopsy for endometrial cancer among members of the European Society of Gynecologic Oncology (ESGO)…
🚨Oncofertility an Option in Unconventional Situations Prof Abu-Rustum & Prof Kahramanoglu & Dr Bilir
🚨Is Fertility Preservation an Option in Unconventional Situations?🎤Interviewee: Prof. Nadeem Abu-Rustum 🎤Interviewer: Prof. Ilker Kahramanoglu & Dr. Esra …